MAVS anticorps (N-Term)
Aperçu rapide pour MAVS anticorps (N-Term) (ABIN303316)
Antigène
Voir toutes MAVS AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Purification
- Purified
-
Immunogène
- Synthetic Peptide corresponding to 13 amino acid peptide from near the amino terminus of human VISA.
-
-
-
-
Indications d'application
-
Immunohistochemistry on Paraffin Sections (5 μg/mL). Western Blot.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Restrictions
- For Research Use only
-
-
-
Buffer
- Phosphate Buffered Saline PBS containing 0.02 % Sodium Azide as preservative.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeated freezing and thawing.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at-20 °C for longer. Dilute only prior to immediate use.
-
-
- MAVS (Mitochondrial Antiviral Signaling Protein (MAVS))
-
Autre désignation
- MAVS
-
Sujet
- MAVS (Mitochondrial Antiviral Signaling) mediates the activation of NF-kappaB and IRF3 in response to antiviral infection. Silencing of MAVS expression permits derepression of viral replication, while over expression of MAVS boosts antiviral immunity.Synonyms: CARD adapter inducing interferon-beta, Cardif, IPS1, Mitochondrial antiviral-signaling protein, Mitochondrial antiviral-signaling protein, Putative NF-kappa-B-activating protein 031N, VISA, Virus-induced-signaling adapter, nterferon-beta promoter stimulator protein 1
-
ID gène
- 57506
-
NCBI Accession
- NP_065797
-
UniProt
- Q7Z434
-
Pathways
- Activation of Innate immune Response, Inositol Metabolic Process, Hepatitis C
Antigène
-